Fadi Haddad: Ghayas Issa presenting the results of AUGMENT-101

Fadi Haddad, Assistant Professor of the Leukemia Department at MD Anderson Cancer Center, Houston, shared a post on X/Twitter:

“Ghayas Issa from MD Anderson Cancer Center presenting the results of AUGMENT-101:

• N=57 evaluable for efficacy
• KMT2Ar leukemias
• Heavily pretreated patients, 46% with >3 prior lines
• CR/CRh=23%, mOS=8 months
• No discontinuation due to DS”

Source: Fadi Haddad/X